Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2024
Reporting Period: Fiscal quarter ended June 30, 2024
Context: The filing serves to announce financial results for the second quarter of 2024 and provide a business update via a press release (Exhibit 99.1).
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references a press release containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not contain specific data to compare against prior periods. It indicates that material changes and results are detailed in the attached press release (Exhibit 99.1), which is incorporated by reference.
Guidance, Outlook, and Risks
Management Commentary: The company issued a business update alongside the financial results, though the specific content of this update is not included in the filing text provided.
Regulatory Note: Information furnished under Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other documents unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2024 revenue, net loss, and cash position figures.
- Verify the details of the "business update" mentioned in Item 2.02 for operational milestones or strategic shifts.
- Check the company's status as an Emerging Growth Company (indicated as yes) for potential differences in financial reporting standards.
- Confirm the trading symbol LUCD on The Nasdaq Stock Market LLC for current market data.